Archive

Nutritional priorities to support GLP-1 therapy for obesity

Written by | 5 Jun 2025

Four leading organizations in lifestyle medicine, obesity medicine, and nutrition—the American College of Lifestyle Medicine (ACLM), the American Society for Nutrition (ASN), the Obesity Medicine Association (OMA), and […]

New study shows obesity linked to long COVID

Written by | 27 May 2025

New research by Edith Cowan University (ECU) Centre of Precision Health visiting PhD scholar Ms Debora Barbosa Ronca found that people with excess weight are more likely to […]

GLP-1 RA medications safe and effective for treating obesity in adults with mental illness

Written by | 25 May 2025

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive […]

First head-to-head study in people living with obesity shows tirzepatide results in around 50% more weight loss than semaglutide

Written by | 18 May 2025

A new head-to-head study of tirzepatide versus semaglutide for weight loss in people living with obesity, but not diabetes, shows that over 72 weeks tirzepatide results in an […]

Repurposed diabetes drug can reduce pain for those with knee arthritis and overweight or obesity: study

Written by | 30 Apr 2025

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has […]

New oral GLP-1RA orforglipron comparable to semaglutide for weight loss

Written by | 22 Apr 2025

Results from the ACHIEVE-1 trial show that treatment with orforglipron was associated with weight loss ranging from 4.7 – 7.9% (4.4 – 7.3 Kg) of body weight in […]

Study estimates proportion of adolescents living with overweight and obesity in England has increased by 50% between 2008 and 2023

Written by | 16 Apr 2025

New research to be presented at this year’s European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14 May) shows that the proportion of adolescents living with overweight or […]

New guidance for managing obesity in children and adolescents

Written by | 15 Apr 2025

A new guideline to help health care providers manage obesity in children and adolescents takes a patient-centred approach, emphasizing behavioural and psychological supports that focus on outcomes valued […]

Obesity Action Coalition & The Obesity Society send letter to FDA on behalf of more than 20 leading organizations & providers urging enforcement of compounding regulations

Written by | 25 Mar 2025

Today, the Obesity Action Coalition (OAC) and The Obesity Society (TOS) sent a letter to the U.S. Food & Drug Administration (FDA), along with more than 20 leading […]

GLP-1 RAs – where are we now? What have we learned?

Written by | 17 Mar 2025

Pharmacist Deborah Evans runs a weight-management clinic at Remedi Health in Winchester. She has helped many people to lose weight and improve their health using the GLP-1 receptor […]

What’s the mechanism behind behavioral side effects of popular weight loss drugs?

Written by | 25 Jan 2025

Glucagon-like peptide 1 receptor agonists (GLP1RA)—medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents—have […]

GLP-1 RA drugs effectively treat obesity in adults without diabetes

Written by | 7 Jan 2025

A meta- analysis of studies evaluating the efficacy and safety of various glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and co-agonists for treating obesity in adults without diabetes, suggests […]

Newsletter Icon

Sign up to our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare news and e-journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Sign Up

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our email journals and publications.